← Back to Treatments
🏅 FDA Orphan Designation

Pyridostigmine Bromide

PYRIDOSTIGMINE BROMIDE

Manufacturer: ANI Pharmaceuticals, Inc.

Indicated for:
Myasthenia gravis

FDA-Approved Indications (1)

useful in the treatment of myasthenia gravis

Population: all ages

Indications & Usage

INDICATIONS AND USAGE Pyridostigmine Bromide Tablets USP are useful in the treatment of myasthenia gravis.

Medical disclaimer: This information is for educational purposes only. Always consult a qualified healthcare provider before making treatment decisions. Data sourced from FDA and current as of our last update.